Thebaine Market to Expand Steadily in the Coming Years till 2018-2026


Posted October 15, 2018 by coherent3

Thebaine is an opioid alkaloid also called as codeine methyl enol ether. Although it is a minor constituent of opium i.e. thebaine is chemically similar to codeine and morphine, thebaine has stimulatory effects instead of depressant effects.

 
Thebaine is an opioid alkaloid also called as codeine methyl enol ether. Although it is a minor constituent of opium i.e. thebaine is chemically similar to codeine and morphine, thebaine has stimulatory effects instead of depressant effects. Thebaine is white crystalline substance, which is slightly soluble in water. It is more lethal substance as compared to morphine therefore it said to be poisonous alkaloid. At high doses thebaine can cause convulsions, which is similar to strychnine poisoning. Synthetic enantiomer of thebaine show analgesic effects, which is mediated through opioid receptors. Pharmacodynamics of thebaine are that it has a stimulatory effect by acting on opioid receptors, which are present in the central nervous system.

Download PDF Brochure of Research Report:
https://www.coherentmarketinsights.com/insight/request-pdf/1908

Thebaine Market drivers:-
Launch of new campaigns to promote drug abuse treatment is expected to be a major driver for growth of global thebaine market. For instance, in 2018, Trump administration i.e. White House Administration launched a multi-million dollar opioid awareness campaign for young adults. This campaign aims at curbing addition of opioid among young population. This campaign also spreads awareness by sharing true life stories of drug addicts to educate teens as well as young adults. According to a survey conducted by Substance Abuse and Mental health Services administration in 2018, opioid crisis kills an average of 116 Americans annually. Such government organized campaigns and high number of people dying due to opioid crisis are expected to encourage people to get rid of substance abuse addiction using different treatments available to live a healthy life.

Market Key Players:-
API Labs Inc., Alcaliber S.A., Sanofi S.A., Faran Shimi pharmaceutical Co., Mallinckrodt Pharmaceuticals, Noramco Inc,. and Tasmania Alkaloids Pvt. Ltd.

Request Customization:
https://www.coherentmarketinsights.com/insight/request-customization/1908

Thebaine Market Regional Analysis:-
North America is expected to hold a dominant position in global thebaine market due to robust pipeline. For instance, New York state Psychiatric Institute’s drug Pioglitazone (oxycodone) has completed Phase 2 clinical trials in 2016. Pioglitazone (oxycodone) is used in the treatment of drug abuse (Opioid Abuse). Launch of new drugs is expected to fuel theabine market growth. For instance, in 2017, ANI Pharmaceuticals Inc., a specialty pharmaceutical company, launched Oxycodone Hydrochloride Oral Solution 100m/5ml. Oxycodone Hydrochloride Oral Solution is used to treat acute pain.
Thebaine Market Taxonomy:-
By Applications:-
• Oxymorphone
• Nalbuphine
• Naltrexone
• Naloxone
• Oxycodone
• Buprenorphine
• Others
By Distribution Channels:-
• Hospitals/Clinics
• Online Pharmacies
• Retail pharmacies
By Region:-
• North America
• Europe
• Latin America
• Asia Pacific
• Middle East
• Africa

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By coherent
Country Antigua and Barbuda
Categories Fitness , Health
Tags hebaine market analysis , thebaine market growth , thebaine market share
Last Updated October 15, 2018